CY1581A - Naphthoxazines - Google Patents

Naphthoxazines Download PDF

Info

Publication number
CY1581A
CY1581A CY1581A CY158192A CY1581A CY 1581 A CY1581 A CY 1581A CY 1581 A CY1581 A CY 1581A CY 158192 A CY158192 A CY 158192A CY 1581 A CY1581 A CY 1581A
Authority
CY
Cyprus
Prior art keywords
compound
methoxy
methyl
hydrogen
offormula
Prior art date
Application number
CY1581A
Other languages
English (en)
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of CY1581A publication Critical patent/CY1581A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C247/00—Compounds containing azido groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CY1581A 1984-06-12 1992-04-03 Naphthoxazines CY1581A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3421729 1984-06-12
DE3508263 1985-03-08

Publications (1)

Publication Number Publication Date
CY1581A true CY1581A (en) 1992-04-03

Family

ID=25822036

Family Applications (1)

Application Number Title Priority Date Filing Date
CY1581A CY1581A (en) 1984-06-12 1992-04-03 Naphthoxazines

Country Status (28)

Country Link
US (1) US4656167A (OSRAM)
JP (1) JPS611676A (OSRAM)
AT (1) AT394717B (OSRAM)
AU (1) AU582751B2 (OSRAM)
BE (1) BE902600A (OSRAM)
CA (1) CA1285561C (OSRAM)
CH (1) CH666031A5 (OSRAM)
CY (1) CY1581A (OSRAM)
DE (1) DE3520104C2 (OSRAM)
DK (1) DK172306B1 (OSRAM)
ES (1) ES8704469A1 (OSRAM)
FI (1) FI86301C (OSRAM)
FR (1) FR2565586B1 (OSRAM)
GB (1) GB2160200B (OSRAM)
GR (1) GR851418B (OSRAM)
HK (1) HK11891A (OSRAM)
HU (1) HU193979B (OSRAM)
IE (1) IE58398B1 (OSRAM)
IL (1) IL75468A (OSRAM)
IT (1) IT1200079B (OSRAM)
LU (1) LU85941A1 (OSRAM)
MY (1) MY102059A (OSRAM)
NL (1) NL194166C (OSRAM)
NZ (1) NZ212358A (OSRAM)
PH (1) PH23666A (OSRAM)
PT (1) PT80634B (OSRAM)
SE (1) SE465428B (OSRAM)
SG (1) SG9691G (OSRAM)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8616669D0 (en) * 1986-07-09 1986-08-13 Merk Sharpe & Dohme Ltd Pharmaceutical compositions
US5071875A (en) * 1989-09-25 1991-12-10 Northwestern University Substituted 2-amidotetralins as melatonin agonists and antagonists
HU214591B (hu) * 1989-12-14 1998-04-28 Novartis Ag. Eljárás egy naftoxazinszármazék malonátsójának és az ilyen hatóanyagot tartalmazó gyógyszerkészítmények előállítására
DE4329776A1 (de) * 1993-09-03 1995-03-09 Sandoz Ag Naphthoxazine, ihre Herstellung und Verwendung
TW357143B (en) * 1995-07-07 1999-05-01 Novartis Ag Benzo[g]quinoline derivatives
JP2011525893A (ja) * 2008-06-27 2011-09-29 ハー・ルンドベック・アクチエゼルスカベット 新規のフェノールアミン類およびカテコールアミン類ならびにそのプロドラッグ

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2194421B1 (OSRAM) * 1972-08-03 1975-10-17 Cerpha
AU521527B2 (en) * 1979-09-12 1982-04-08 Dow Chemical Company, The Dehydrohalogenation of (polyhaloalkyl) benzenes
US4368201A (en) * 1981-07-20 1983-01-11 Usv Pharmaceutical Corporation Tetrahydronaphthoxazoles
CA1204745A (en) * 1981-11-20 1986-05-20 Merck Co. Hexahydronaphth (1,2-b) -1,4 -oxazines
US4420480A (en) * 1981-11-20 1983-12-13 Merck & Co., Inc. Hexahydronaphth[1,2-b]-1,4-oxazines
DE4003262A1 (de) * 1990-02-03 1991-08-08 Sandoz Ag Neues naphthoxazin, seine herstellung und verwendung

Also Published As

Publication number Publication date
DK259185A (da) 1985-12-13
ATA172385A (de) 1991-11-15
JPS611676A (ja) 1986-01-07
GB2160200B (en) 1988-03-16
IE851437L (en) 1985-12-12
LU85941A1 (fr) 1986-01-24
IL75468A0 (en) 1985-10-31
AT394717B (de) 1992-06-10
MY102059A (en) 1992-03-31
ES8704469A1 (es) 1987-04-01
NL8501526A (nl) 1986-01-02
PT80634A (en) 1985-07-01
HK11891A (en) 1991-02-22
SE465428B (sv) 1991-09-09
IL75468A (en) 1989-05-15
IE58398B1 (en) 1993-09-08
IT1200079B (it) 1989-01-05
CH666031A5 (de) 1988-06-30
NL194166C (nl) 2001-08-03
JPH0576472B2 (OSRAM) 1993-10-22
PH23666A (en) 1989-09-27
CA1285561C (en) 1991-07-02
IT8548195A0 (it) 1985-06-11
SE8502865D0 (sv) 1985-06-10
GR851418B (OSRAM) 1985-11-25
US4656167A (en) 1987-04-07
FI852325A0 (fi) 1985-06-11
HU193979B (en) 1987-12-28
FI86301C (fi) 1992-08-10
SG9691G (en) 1991-04-05
NZ212358A (en) 1989-01-27
AU582751B2 (en) 1989-04-13
DE3520104A1 (de) 1985-12-12
FR2565586A1 (fr) 1985-12-13
GB2160200A (en) 1985-12-18
DK259185D0 (da) 1985-06-10
ES544074A0 (es) 1987-04-01
NL194166B (nl) 2001-04-02
BE902600A (fr) 1985-12-06
GB8514636D0 (en) 1985-07-10
DE3520104C2 (de) 1997-01-23
FR2565586B1 (fr) 1989-09-15
PT80634B (pt) 1987-10-20
SE8502865L (sv) 1985-12-13
DK172306B1 (da) 1998-03-09
FI852325L (fi) 1985-12-13
FI86301B (fi) 1992-04-30
AU4345885A (en) 1985-12-19
HUT39438A (en) 1986-09-29

Similar Documents

Publication Publication Date Title
SU1029827A3 (ru) Способ получени меркаптозамещенных 2,3,4,5-тетрагидро-1 @ -3-бензазепинов или их солей
US4224329A (en) 2-Substituted-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indoles
EP0080115B1 (en) Hexahydronaphth(1,2-b)-1,4-oxazines, process for their preparation and pharmaceutical formulation containing them
US4420480A (en) Hexahydronaphth[1,2-b]-1,4-oxazines
US5026855A (en) Stereospecific process for the preparation of furo[3,4-c]pyridine, enantiomer, compounds thus obtained and therapeutical compositions thereof
GB2134515A (en) Benzoquinolines
EP0256888B1 (en) Benzothiazepine vasodilators having aralkyl substitution
US4243805A (en) 3 Fluoro-10-piperazino-8-substituted 10,11-dihydrodibenzo-(bf) thiepins and method for the preparation thereof
CA1285561C (en) Naphthoxazines
Hino et al. Agents Acting on the Central Nervous System.: Synthesis of 3-Phenyl-2-piperazinyl-1-benzazocines, 3-Substituted-2-piperazinyl-1-benzazepines and Related Compounds
US3972936A (en) 10,11-Dihydro-5-(3-amino-propyl-or-propylidene)-10,10,11,11-tetra-fluoro-5H-dibenzo[a,d]cycloheptenes and-5-ols
US4158059A (en) Tension reducing 2,3,4,4a,9,136-hexahydro-dibenz[1,2;5,6]cyclohepta[3,4-c]py
NZ195702A (en) 7-(3-(isopropyl or t-butyl)amino-2-hydroxypropoxy)-indolin-2,3-diones
US4729994A (en) Benzothiazepine vasodilators having aralkyl substitution
US3898224A (en) 1,6,7,8-Tetrahydro-4-oxo-4H-pyrido {8 1,2-A{9 pyrimidine-9-carboalkoxy compounds
US4333935A (en) Antianxiety compositions of 10-hydroxy 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino-1,2a azepines and a method of use thereof
EP0061899B1 (en) Morpholines
US4267331A (en) Process for the production of 2-substituted pyrido[4,3-b]-indoles
EP0205264B1 (en) Condensed seven-membered heterocyclic compounds, their production and use
EP0246633B1 (en) Trans-benzopyran-[4,3-b]-1,4-oxazine derivatives
AU622506B2 (en) Novel derivatives of 1,7-(imidazo-(1,2-a)pyridine)5'-6'h) ones
GB2024818A (en) Phenanthrene derivatives, their preparation and pharmaceutical compositions containing them
US4522946A (en) Dioxy hexahydrobenzo[6,7]cyclohepta[1,2,3-de]isoquinoline derivatives useful as neuroleptic agents
US4713386A (en) Tetrahydroazeto [2,1-a]isoquinolines and methods for treating depression
US4177275A (en) Tension reducing 2,3,4,4a,9,13b-hexahydro-1H-dibenzo[b,f]pyrido[3,4-d]azepine derivatives